Salvador JAR - Search Results

1

Editorial: Head & Neck Cancer and Esophageal Cancer: From Biosignatures to Therapeutics.

Kok VC, Yu CC, Salvador JAR. Kok VC, et al. Among authors: salvador jar. Front Oncol. 2021 Mar 19;11:666103. doi: 10.3389/fonc.2021.666103. eCollection 2021. Front Oncol. 2021. PMID: 33816319 Free PMC article. No abstract available.

2

Highlights in USP7 inhibitors for cancer treatment.

Oliveira RI, Guedes RA, Salvador JAR. Oliveira RI, et al. Among authors: salvador jar. Front Chem. 2022 Sep 15;10:1005727. doi: 10.3389/fchem.2022.1005727. eCollection 2022. Front Chem. 2022. PMID: 36186590 Free PMC article. Review.

3

Computational Approaches for the Discovery of Human Proteasome Inhibitors: An Overview.

Guedes RA, Serra P, Salvador JA, Guedes RC. Guedes RA, et al. Molecules. 2016 Jul 16;21(7):927. doi: 10.3390/molecules21070927. Molecules. 2016. PMID: 27438821 Free PMC article. Review.

4

Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment.

Coimbra JRM, Marques DFF, Baptista SJ, Pereira CMF, Moreira PI, Dinis TCP, Santos AE, Salvador JAR. Coimbra JRM, et al. Among authors: salvador jar. Front Chem. 2018 May 24;6:178. doi: 10.3389/fchem.2018.00178. eCollection 2018. Front Chem. 2018. PMID: 29881722 Free PMC article. Review.

5

Chemical Patterns of Proteasome Inhibitors: Lessons Learned from Two Decades of Drug Design.

Guedes RA, Aniceto N, Andrade MAP, Salvador JAR, Guedes RC. Guedes RA, et al. Among authors: salvador jar. Int J Mol Sci. 2019 Oct 25;20(21):5326. doi: 10.3390/ijms20215326. Int J Mol Sci. 2019. PMID: 31731563 Free PMC article.

6

Revisiting Proteasome Inhibitors: Molecular Underpinnings of Their Development, Mechanisms of Resistance and Strategies to Overcome Anti-Cancer Drug Resistance.

Leonardo-Sousa C, Carvalho AN, Guedes RA, Fernandes PMP, Aniceto N, Salvador JAR, Gama MJ, Guedes RC. Leonardo-Sousa C, et al. Among authors: salvador jar. Molecules. 2022 Mar 28;27(7):2201. doi: 10.3390/molecules27072201. Molecules. 2022. PMID: 35408601 Free PMC article. Review.

7

Deep generative model for therapeutic targets using transcriptomic disease-associated data-USP7 case study.

Pereira T, Abbasi M, Oliveira RI, Guedes RA, Salvador JAR, Arrais JP. Pereira T, et al. Among authors: salvador jar. Brief Bioinform. 2022 Jul 18;23(4):bbac270. doi: 10.1093/bib/bbac270. Brief Bioinform. 2022. PMID: 35789255

8

CYP17 inhibitors for prostate cancer treatment--an update.

Moreira VM, Salvador JA, Vasaitis TS, Njar VC. Moreira VM, et al. Curr Med Chem. 2008;15(9):868-99. doi: 10.2174/092986708783955428. Curr Med Chem. 2008. PMID: 18473796 Review.

9

Synthesis and cytotoxic activity of novel A-ring cleaved ursolic acid derivatives in human non-small cell lung cancer cells.

Mendes VIS, Bartholomeusz GA, Ayres M, Gandhi V, Salvador JAR. Mendes VIS, et al. Among authors: salvador jar. Eur J Med Chem. 2016 Nov 10;123:317-331. doi: 10.1016/j.ejmech.2016.07.045. Epub 2016 Jul 22. Eur J Med Chem. 2016. PMID: 27484517 Free PMC article.

10

Corrigendum to "Synthesis and cytotoxic activity of novel A-ring cleaved ursolic acid derivatives in human non-small cell lung cancer cells" [Eur. J. Med. Chem. 123 (2016) 317-331].

Mendes VIS, Bartholomeusz GA, Ayres M, Gandhi V, Salvador JAR. Mendes VIS, et al. Among authors: salvador jar. Eur J Med Chem. 2016 Nov 29;124:1004-1005. doi: 10.1016/j.ejmech.2016.09.088. Epub 2016 Oct 23. Eur J Med Chem. 2016. PMID: 27783971 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page